Studies were included if they evaluated serum PLA2R antibody assays as a diagnostic test in patients with nephrotic syndrome, used renal biopsy as the reference standard, and reported or allowed calculation of diagnostic accuracy measures such as sensitivity and specificity. Here, PLA2R1 is linked to nephrotic syndrome.